ETF Holdings Breakdown of CC

CC institutional holdings

The adjusted close for CC on 2025-11-12 was 12.61

The following institutional investment holdings of CC have been identified

Date	ETF ISIN/Name	Num Shares	Book value	Derived Price per Share	Comment
2025-11-12	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	110,517	USD 1,393,619 -0.3%	12.61
2025-11-12	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	16,247 -0.3%	USD 204,875 -0.6%	12.61
2025-11-12	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	1,086	USD 13,694 -0.3%	12.61
Total =		127,850	USD 1,612,188

Book value of shares is calculated on the adjusted close price of each day (row).

News associated with CC

Truist Financial Issues Positive Forecast for Chemours (NYSE:CC) Stock Price

Chemours (NYSE:CC – Free Report) had its target price increased by Truist Financial from $18.00 to $21.00 in a research note issued to investors on Tuesday morning,Benzinga reports. They currently have a buy rating on the specialty chemicals company’s stock. A number of other equities research analysts have also recently commented on the stock. Royal […] - 2025-09-17 03:06:59

The Chemours Company (NYSE:CC) Receives $17.38 Average Price Target from Analysts

The Chemours Company (NYSE:CC – Get Free Report) has been given an average recommendation of “Moderate Buy” by the nine ratings firms that are covering the firm, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12-month […] - 2025-09-08 02:32:51

YieldBoost CC From 2.4% To 12.4% Using Options

Shareholders of Chemours Co (Symbol: CC) looking to boost their income beyond the stock's 2.4% annualized dividend yield can sell the January 2027 covered call at the $22 strike and collect the premium based on the $2.05 bid, which annualizes to an additional 10% rate of return - 2025-09-03 12:41:55

Chemours Reaches Analyst Target Price

In recent trading, shares of Chemours Co (Symbol: CC) have crossed above the average analyst 12-month target price of $14.90, changing hands for $15.07/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation - 2025-08-15 09:39:05

Chemours (NYSE:CC) Shares Gap Up Following Insider Buying Activity

The Chemours Company (NYSE:CC – Get Free Report)’s share price gapped up before the market opened on Wednesday after an insider bought additional shares in the company. The stock had previously closed at $12.42, but opened at $13.00. Chemours shares last traded at $13.60, with a volume of 918,108 shares trading hands. Specifically, CEO Denise […] - 2025-08-15 02:34:47

Brokerages Set The Chemours Company (NYSE:CC) Price Target at $17.38

The Chemours Company (NYSE:CC – Get Free Report) has been given an average recommendation of “Moderate Buy” by the eight analysts that are presently covering the firm, Marketbeat reports. Three investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 12-month price target […] - 2025-08-14 02:32:51

Mutual of America Capital Management LLC Has $294,000 Stock Holdings in The Chemours Company (NYSE:CC)

Mutual of America Capital Management LLC lowered its stake in shares of The Chemours Company (NYSE:CC – Free Report) by 72.4% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 21,756 shares of the specialty chemicals company’s stock after selling 57,169 shares […] - 2025-08-13 05:46:49

PNC Financial Services Group Inc. Acquires 7,688 Shares of The Chemours Company (NYSE:CC)

PNC Financial Services Group Inc. lifted its position in The Chemours Company (NYSE:CC – Free Report) by 17.1% during the first quarter, Holdings Channel reports. The institutional investor owned 52,600 shares of the specialty chemicals company’s stock after buying an additional 7,688 shares during the quarter. PNC Financial Services Group Inc.’s holdings in Chemours were […] - 2025-08-13 05:12:50

Universal Beteiligungs und Servicegesellschaft mbH Invests $174,000 in The Chemours Company (NYSE:CC)

Universal Beteiligungs und Servicegesellschaft mbH bought a new position in The Chemours Company (NYSE:CC – Free Report) in the first quarter, HoldingsChannel reports. The firm bought 12,857 shares of the specialty chemicals company’s stock, valued at approximately $174,000. A number of other institutional investors and hedge funds have also recently modified their holdings of CC. […] - 2025-08-06 04:31:04

Mutual of America Capital Management LLC Sells 57,169 Shares of The Chemours Company (NYSE:CC)

Mutual of America Capital Management LLC lessened its position in shares of The Chemours Company (NYSE:CC – Free Report) by 72.4% in the first quarter, according to its most recent filing with the SEC. The firm owned 21,756 shares of the specialty chemicals company’s stock after selling 57,169 shares during the quarter. Mutual of America […] - 2025-07-24 04:37:01

The Chemours Company (NYSE:CC) Given Average Rating of “Moderate Buy” by Brokerages

The Chemours Company (NYSE:CC – Get Free Report) has received a consensus rating of “Moderate Buy” from the nine ratings firms that are presently covering the firm, MarketBeat reports. Four analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 12-month target price among […] - 2025-07-22 03:29:04

Brown Advisory Inc. Has $282,000 Position in The Chemours Company (NYSE:CC)

Brown Advisory Inc. lifted its position in shares of The Chemours Company (NYSE:CC – Free Report) by 6.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 20,874 shares of the specialty chemicals company’s stock after purchasing an additional 1,174 shares during the period. […] - 2025-07-17 05:26:51

Nisa Investment Advisors LLC Has $273,000 Stock Position in The Chemours Company (NYSE:CC)

Nisa Investment Advisors LLC grew its position in The Chemours Company (NYSE:CC – Free Report) by 124.4% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 20,187 shares of the specialty chemicals company’s stock after acquiring an additional 11,192 shares during the quarter. Nisa […] - 2025-07-17 04:48:56

Principal Financial Group Inc. Purchases 399,097 Shares of The Chemours Company (NYSE:CC)

Principal Financial Group Inc. increased its position in The Chemours Company (NYSE:CC – Free Report) by 116.3% in the first quarter, Holdings Channel.com reports. The fund owned 742,119 shares of the specialty chemicals company’s stock after acquiring an additional 399,097 shares during the quarter. Principal Financial Group Inc.’s holdings in Chemours were worth $10,041,000 at […] - 2025-07-15 04:42:23

Teacher Retirement System of Texas Takes Position in The Chemours Company (NYSE:CC)

Teacher Retirement System of Texas purchased a new stake in shares of The Chemours Company (NYSE:CC – Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 58,994 shares of the specialty chemicals company’s stock, valued at approximately $798,000. Several […] - 2025-07-15 04:41:43

Oregon Public Employees Retirement Fund Buys 3,773 Shares of The Chemours Company (NYSE:CC)

Oregon Public Employees Retirement Fund boosted its holdings in The Chemours Company (NYSE:CC – Free Report) by 12.4% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 34,200 shares of the specialty chemicals company’s stock after acquiring an additional 3,773 shares during the […] - 2025-07-09 05:33:06

New York State Teachers Retirement System Purchases 7,058 Shares of The Chemours Company (NYSE:CC)

New York State Teachers Retirement System raised its stake in shares of The Chemours Company (NYSE:CC – Free Report) by 3.9% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 188,447 shares of the specialty chemicals company’s stock after buying an additional 7,058 shares […] - 2025-07-08 04:40:55

Chemours (NYSE:CC) Given New $15.00 Price Target at Royal Bank Of Canada

Chemours (NYSE:CC – Free Report) had its price objective boosted by Royal Bank Of Canada from $14.00 to $15.00 in a report published on Thursday,Benzinga reports. The brokerage currently has an outperform rating on the specialty chemicals company’s stock. CC has been the topic of several other research reports. Wall Street Zen downgraded shares of […] - 2025-07-04 05:06:11

Bessemer Group Inc. Purchases 3,081 Shares of The Chemours Company (NYSE:CC)

Bessemer Group Inc. raised its position in The Chemours Company (NYSE:CC – Free Report) by 8.7% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 38,554 shares of the specialty chemicals company’s stock after purchasing an additional 3,081 shares during the […] - 2025-07-02 04:55:08

SG Americas Securities LLC Takes $822,000 Position in The Chemours Company (NYSE:CC)

SG Americas Securities LLC acquired a new stake in shares of The Chemours Company (NYSE:CC – Free Report) during the 1st quarter, Holdings Channel.com reports. The fund acquired 60,734 shares of the specialty chemicals company’s stock, valued at approximately $822,000. Several other large investors also recently bought and sold shares of the business. UMB Bank […] - 2025-06-20 05:12:53

Public Employees Retirement System of Ohio Cuts Position in The Chemours Company (NYSE:CC)

Public Employees Retirement System of Ohio decreased its stake in The Chemours Company (NYSE:CC – Free Report) by 5.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 51,210 shares of the specialty chemicals company’s stock after selling 2,932 shares during the period. […] - 2025-06-04 04:56:53

Barclays Lowers Chemours (NYSE:CC) Price Target to $13.00

Chemours (NYSE:CC – Get Free Report) had its target price cut by Barclays from $16.00 to $13.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has an “equal weight” rating on the specialty chemicals company’s stock. Barclays‘s price objective points to a potential upside of 28.52% from the […] - 2025-05-30 02:54:44

Cetera Investment Advisers Purchases 12,190 Shares of The Chemours Company (NYSE:CC)

Cetera Investment Advisers raised its position in shares of The Chemours Company (NYSE:CC – Free Report) by 89.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 25,792 shares of the specialty chemicals company’s stock after acquiring an additional 12,190 shares during […] - 2025-05-29 05:08:51

Chemours (NYSE:CC) Rating Lowered to “Sell” at StockNews.com

Chemours (NYSE:CC – Get Free Report) was downgraded by StockNews.com from a “hold” rating to a “sell” rating in a note issued to investors on Wednesday. CC has been the topic of a number of other reports. Truist Financial reduced their target price on shares of Chemours from $27.00 to $22.00 and set a “buy” […] - 2025-05-21 04:38:49

Mercer Global Advisors Inc. ADV Makes New $301,000 Investment in The Chemours Company (NYSE:CC)

Mercer Global Advisors Inc. ADV bought a new position in shares of The Chemours Company (NYSE:CC – Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The fund bought 17,840 shares of the specialty chemicals company’s stock, valued at approximately $301,000. Other hedge funds and other institutional investors […] - 2025-05-16 04:49:01

Chemours (NYSE:CC) versus Aduro Clean Technologies (NASDAQ:ADUR) Financial Analysis

Aduro Clean Technologies (NASDAQ:ADUR – Get Free Report) and Chemours (NYSE:CC – Get Free Report) are both small-cap manufacturing companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, dividends, analyst recommendations, profitability, risk, institutional ownership and valuation. Valuation and Earnings This table compares Aduro […] - 2025-05-14 02:34:50

Comerica Bank Sells 3,614 Shares of The Chemours Company (NYSE:CC)

Comerica Bank reduced its position in shares of The Chemours Company (NYSE:CC – Free Report) by 5.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 57,240 shares of the specialty chemicals company’s stock after selling 3,614 shares during the period. Comerica […] - 2025-05-13 06:01:05

The Chemours Company (NYSE:CC) Shares Purchased by Northern Trust Corp

Northern Trust Corp lifted its stake in The Chemours Company (NYSE:CC – Free Report) by 25.1% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 1,301,808 shares of the specialty chemicals company’s stock after acquiring an additional 261,009 shares during the quarter. Northern Trust Corp’s […] - 2025-05-13 05:28:52

Now Is Not The Time To Buy Chemours Stock

Chemours (NYSE:CC) stock looks unattractive – making it a bad pick to buy at its current price of around $11. We believe there are several major concerns with CC stock, which makes it unattractive despite its current valuation being low. - 2025-05-13 01:46:08

Voya Investment Management LLC Sells 1,448 Shares of The Chemours Company (NYSE:CC)

Voya Investment Management LLC reduced its stake in The Chemours Company (NYSE:CC – Free Report) by 6.3% during the 4th quarter, HoldingsChannel reports. The fund owned 21,663 shares of the specialty chemicals company’s stock after selling 1,448 shares during the quarter. Voya Investment Management LLC’s holdings in Chemours were worth $366,000 as of its most […] - 2025-05-12 05:32:50

Back to Listing

Disclaimer